FOR IMMEDIATE RELEASE

24 July 2020 (Ottawa, ON) – ICAD congratulates the International Partnership on Microbicides (IPM) on its announcement today that the European Medicine’s Agency (EMA) has issued a positive opinion on the dapivirine ring for use by cisgender women ages 18 and older in developing countries to reduce their risk of HIV-1 infection. This announcement is a turning point in the long path towards providing women with an efficacious and affordable HIV prevention option over which they have full control.

The EMA’s opinion is a game changer and we extend a heartfelt congratulations to the scientists, advocates, policy makers, regulators, community members and most of all, to the … Read more →